Loading organizations...
EFI Lake Geneva Ventures operates as a seed and early-stage investment fund, deploying capital into innovative companies across biotech, fintech, medtech, and deep tech. The firm primarily supports nascent ventures throughout Europe, with a distinct focus on Swiss innovation. Its strategy identifies and cultivates promising enterprises during their formative stages, aiming to foster growth within these high-potential sectors.
Established in Geneva, Switzerland, in 2020, the firm emerged to address critical funding gaps for early-stage companies. Its formation reflects a strategic commitment to strengthening the European innovation landscape through targeted venture capital. While specific founders are not detailed, the firm plays a vital role in nurturing nascent technological advancements, contributing to the development of future industry leaders.
The firm serves early-stage founders by providing essential capital to develop and scale pioneering technologies. Its portfolio companies typically span life sciences, financial technology, and advanced engineering. EFI Lake Geneva Ventures' vision is to empower European innovators with crucial early-stage funding and strategic guidance, fostering significant technological advancement and sustained market presence.
EFI Lake Geneva Ventures has 4 tracked investments across 4 companies. The latest tracked deal is $15.5M Series B in Hemotune in March 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 29, 2024 | Hemotune | $15.5M Series B | Darius Madjdpour | Pascal Winnen, Cedric Barra, Annick BAY, Z%C3%BCrcher%20Kantonalbank |
| Jun 28, 2023 | EBAMed | $15.7M Series A | EIC Fund, Barbara Castellano | LIFTT, Mayo Clinic, Occident |
| Feb 1, 2023 | FluoSphera | $1.0M Seed | — | SOSV, Mountain Labs |
| Dec 3, 2021 | Hylomorph | $5.7M Series B | Geneva Smart Invest, StartAngels Network | Verve Ventures, Zürcher Kantonalbank |